» Articles » PMID: 8149669

Persistence of Virus and Viral Genome in Myocardium After Coxsackievirus B3-induced Murine Myocarditis

Overview
Date 1994 Apr 1
PMID 8149669
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Following infection with Coxsackievirus B3 (CVB3), A-strain mice develop ongoing myocarditis that persists after the virus ceases to be cultivatable from heart tissue. We studied the natural history of this virus-induced but apparently autoimmune inflammation by means of in situ hybridization (ISH) and by polymerase chain reaction (PCR). Both ISH and culture allowed detection of virus up to 2 weeks post-infection in virtually all heart tissues. In contrast, PCR revealed the presence of viral genome for a substantially longer period of time, i.e. at least 34 days after CVB3 infection. Similarly, the majority of mice showed myocardial inflammation at this time point. However, the persistence of virus did not correlate with ongoing myocarditis, and vice versa. Most mice with ongoing myocarditis produced heart myosin autoantibodies, most probably as a result of tissue damage. The lack of correlation between presence of ongoing inflammation and persistence of virus supports our previous view that the late phase of CVB3-induced myocarditis is mediated by autoimmunological mechanisms.

Citing Articles

Viral myocarditis involves the generation of autoreactive T cells with multiple antigen specificities that localize in lymphoid and non-lymphoid organs in the mouse model of CVB3 infection.

Basavalingappa R, Arumugam R, Lasrado N, Yalaka B, Massilamany C, Gangaplara A Mol Immunol. 2020; 124:218-228.

PMID: 32615275 PMC: 7363587. DOI: 10.1016/j.molimm.2020.06.017.


Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T J Transl Med. 2018; 16(1):268.

PMID: 30285773 PMC: 6167797. DOI: 10.1186/s12967-018-1644-y.


Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.

Flynn C, Kimura T, Frimpong-Boateng K, Harkins S, Whitton J Virology. 2017; 512:104-112.

PMID: 28950225 PMC: 5653433. DOI: 10.1016/j.virol.2017.09.017.


Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.

Smithee S, Tracy S, Chapman N J Virol. 2015; 89(23):11761-72.

PMID: 26355088 PMC: 4645312. DOI: 10.1128/JVI.01308-15.


Cardiomyopathies and myocardial disorders in Africa: present status and the way forward.

Falase A, Ogah O Cardiovasc J Afr. 2012; 23(10):552-62.

PMID: 23192260 PMC: 3721909. DOI: 10.5830/CVJA-2012-046.


References
1.
Lerner A, Wilson F . Virus myocardiopathy. Prog Med Virol. 1973; 15:63-91. View

2.
Keeling P, Jeffery S, Caforio A, Taylor R, Bottazzo G, Davies M . Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction. Br Heart J. 1992; 68(6):554-9. PMC: 1025684. DOI: 10.1136/hrt.68.12.554. View

3.
Kandolf R, Hofschneider P . Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci U S A. 1985; 82(14):4818-22. PMC: 390996. DOI: 10.1073/pnas.82.14.4818. View

4.
Hamada H, Reddy P, KAKUNAGA T . Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci U S A. 1985; 82(18):6133-7. PMC: 391006. DOI: 10.1073/pnas.82.18.6133. View

5.
Wolfgram L, Beisel K, Herskowitz A, Rose N . Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. J Immunol. 1986; 136(5):1846-52. View